fainting on semaglutide Some people are overdosing semaglutide, FDA warns | What you should know FDA Warns Against Using Compounded

As mounting evidence confirms their role in reducing cardiovascular morbidity and mortality, GLP-1 receptor agonists will undoubtedly become standard components of cardiovascular risk reduction strategies

Cross-sectional research studies have demonstrated a correlation between heightened fat intake and diminished insulin sensitivity

The shift toward parasympathetic tone reduces resting heart rate variability, decreases cardiac workload, and promotes arterial relaxation

Our telehealth services are designed to be convenient, accessible, and patient-centered

Fixed-dose combination pen containing both cagrilintide and semaglutide

No solo endocrinos, un abordaje interdisciplinar es el que marca el xito porque sabemos que la obesidad es una enfermedad crnica y recurrente y tenemos que ayudar al paciente, acompaarle y por supuesto quitarle el estigma: no padece obesidad porque quiere